methylprednisolone has been researched along with Atypical Hemolytic-Uremic Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burns, A; Gandhi, V; Goodship, T | 1 |
Chen, Q; He, YD; Song, D; Song, WC; Wang, FM; Wang, SX; Xu, BN; Yu, F; Yu, XJ; Zhao, MH | 1 |
Acar, B; Başaran, Ö; Çakar, N; Kiremitçi, S; Köksoy, A; Taktak, A; Uncu, N | 1 |
3 other study(ies) available for methylprednisolone and Atypical Hemolytic-Uremic Syndrome
Article | Year |
---|---|
A complementary component to atypical haemolytic uraemic syndrome.
Topics: Adult; Atypical Hemolytic Uremic Syndrome; Complement System Proteins; Diagnosis, Differential; Hemolytic-Uremic Syndrome; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Mutation; Treatment Outcome; Young Adult | 2013 |
Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
Topics: Adult; Atypical Hemolytic Uremic Syndrome; Autoantibodies; Biopsy; Complement Activation; Complement Factor H; Complement Factor I; Complement Pathway, Alternative; Female; Humans; Immunologic Factors; Kidney; Methylprednisolone; Polymorphism, Single Nucleotide; Postpartum Period; Pregnancy | 2015 |
An unexpected diagnostic course of systemic lupus erythematosus.
Topics: Adolescent; Atypical Hemolytic Uremic Syndrome; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Plasma; Recurrence | 2016 |